Genetic analysis in myeloid neoplasms

Analysis of related genes in myeloproliferative neoplasms and related diseases - Genetic analysis in myeloproliferative neoplasms

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048023

Enrollment

Registered

2022-06-17

Start date

2022-06-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myeloproliferative neoplasms and related diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Patients with myeloproliferative neoplasms or related diseases who have been admitted to the Department of Hematology, International University of Health and Welfare Narita Hospital during the period from the time of the Ethics Committee's approval until January 31, 2023. (2) Patients who can obtain voluntary consent to participate in research in writing from the principal. (3) Patients whose age at the time of obtaining consent is 18 years or older. (4) In cases where familial onset is suspected, family members are also eligible.

Exclusion criteria

Exclusion criteria: (1) Patients judged by the Research Supervisor to be inappropriate as a test subject. (2) Cases considered to be reactive cythemia.

Design outcomes

Primary

Measure	Time frame
Genetic mutations	—

Secondary

Measure	Time frame
Mode of onset Progression	—

Countries

Japan

Contacts

Public ContactNaoki Mori

International University of Health and Welfare Narita Hospital Hematology

mmoridh@iuhw.ac.jp0476355600

Outcome results